Congress Wealth Management LLC DE Sells 30,171 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Congress Wealth Management LLC DE lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 58.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,572 shares of the healthcare conglomerate’s stock after selling 30,171 shares during the quarter. Congress Wealth Management LLC DE’s holdings in UnitedHealth Group were worth $10,913,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Get Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Trading Up 0.0 %

Shares of UnitedHealth Group stock opened at $516.94 on Tuesday. The firm’s 50-day moving average price is $509.71 and its 200 day moving average price is $546.15. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market capitalization of $472.85 billion, a PE ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company earned $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.